According to Redhill Biopharma's latest financial reports the company's current EPS (TTM) is -604,45ย โฌ. In 2017 the company made an earnings per share (EPS) of -2.159ย โฌ a decrease over its 2016 EPS that were of -1.900ย โฌ.